Rice Biotech Launch Pad startup Motif Neurotech closes Series A financing of $18.75 million
Rice University today announced that Motif Neurotech, a neurotechnology developing minimally invasive bioelectronics for mental health formed through the Rice Biotech Launch Pad, closed an oversubscribed Series A financing round of $18.75 million.
Reducing newborn deaths across Africa enters Phase 2 with $65M
The Newborn Essential Solutions and Technologies (NEST360) international alliance launches Phase 2 of its mission to reduce newborn mortality in sub-Saharan Africa with $65 million in funding from the Bill & Melinda Gates Foundation, the Children’s Investment Fund Foundation, The ELMA Foundation, and generous individual contributions.
Rice’s Medical Humanities Research Institute has transformational agenda
Rice University recently launched its Medical Humanities Research Institute, the only institute in the United States and one of the few in the world that is solely dedicated to advancing translational research on human experiences of health and illness.
Feds fund $45M Rice-led research that could slash US cancer deaths by 50%
The Advanced Research Projects Agency for Health has awarded a Rice-led team $45 million to rapidly develop an implant with sense-and-respond technology that could slash U.S. cancer-related deaths by more than 50%.
Rice University today introduced the Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of the university’s health and medical technology discoveries into cures.
